Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy.
Mehul SharmaMaggie P FuHenry Y LuAshish A SharmaBhavi P ModiChristina MichalskiSusan LinJoshua DalmannAreesha SalmanKate L Del BelMeriam WaqasJefferson TerryAudi SetiadiPascal M LavoieWyeth W WassermanJill MwenifumboMichael S KoborAnna F LeeFlorian KuchenbauerAnna LehmanSylvia ChengAnthony CooperMillan S PatelSuzanne C ToughPublished in: Blood (2022)
The discovery of humans with monogenic disorders has a rich history of generating new insights into biology. Here we report the first human identified with complete deficiency of nuclear factor of activated T cells 1 (NFAT1). NFAT1, encoded by NFATC2, mediates calcium-calcineurin signals that drive cell activation, proliferation, and survival. The patient is homozygous for a damaging germline NFATC2 variant (c.2023_2026delTACC; p.Tyr675Thrfs∗18) and presented with joint contractures, osteochondromas, and recurrent B-cell lymphoma. Absence of NFAT1 protein in chondrocytes caused enrichment in prosurvival and inflammatory genes. Systematic single-cell-omic analyses in PBMCs revealed an environment that promotes lymphomagenesis with accumulation of naïve B cells (enriched for oncogenic signatures MYC and JAK1), exhausted CD4+ T cells, impaired T follicular helper cells, and aberrant CD8+ T cells. This work highlights the pleiotropic role of human NFAT1, will empower the diagnosis of additional patients with NFAT1 deficiency, and further defines the detrimental effects associated with long-term use of calcineurin inhibitors.
Keyphrases
- nuclear factor
- single cell
- toll like receptor
- endothelial cells
- induced pluripotent stem cells
- pluripotent stem cells
- rna seq
- induced apoptosis
- high throughput
- mesenchymal stem cells
- signaling pathway
- replacement therapy
- case report
- cell therapy
- diffuse large b cell lymphoma
- dna methylation
- cell death
- regulatory t cells
- cell cycle arrest
- bone marrow
- smoking cessation